Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
about
Diabetic Macular EdemaDiabetic Retinopathy: Animal Models, Therapies, and PerspectivesImmunopathogenic Background of Pars PlanitisDexamethasone intravitreal implant in the treatment of diabetic macular edemaFunctions of Müller cell-derived vascular endothelial growth factor in diabetic retinopathyContribution of microglia-mediated neuroinflammation to retinal degenerative diseasesNitric oxide and reactive oxygen species in the pathogenesis of preeclampsiaReduced gap junctional communication among astrocytes in experimental diabetes: contributions of altered connexin protein levels and oxidative-nitrosative modifications.Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: implication in the development of retinopathyCalcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetesOcular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic ratsOxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic RetinopathyHeme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity.Vascular dysfunction in retinopathy-an emerging role for arginaseLoss of synaptic connectivity, particularly in second order neurons is a key feature of diabetic retinal neuropathy in the Ins2Akita mouse.Folic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome.Diabetic macular edema: new concepts in patho-physiology and treatment.The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy.The tight junction associated signalling proteins ZO-1 and ZONAB regulate retinal pigment epithelium homeostasis in mice.Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation.Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein.Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases.Evaluation of leukocyte-endothelial interactions in retinal diseases.Etiology and treatment of the inflammatory causes of cystoid macular edema.Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakageTNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeabilityProtection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function.Validation of structural and functional lesions of diabetic retinopathy in miceEndothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits.Preconditioning with endoplasmic reticulum stress mitigates retinal endothelial inflammation via activation of X-box binding protein 1.12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidaseInducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.Intracavernous delivery of a designed angiopoietin-1 variant rescues erectile function by enhancing endothelial regeneration in the streptozotocin-induced diabetic mouseExpression of thrombospondin-1 modulates the angioinflammatory phenotype of choroidal endothelial cells.CD40 promotes the development of early diabetic retinopathy in miceTargeting Neovascularization in Ischemic Retinopathy: Recent AdvancesTNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosisNeurovascular interaction and the pathophysiology of diabetic retinopathyPlasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.
P2860
Q26749438-254425E4-C6E2-4A70-AEC7-09B2ABE91F6BQ26765466-0E7AED28-2FB3-4A50-A6AB-DC60B4756E3BQ26781909-C2F263A7-EB46-401F-B74D-97DC29324416Q26799423-0EB4E0B2-6BC1-443E-915D-847A4D30EDBDQ26824541-F7DCA50B-90D9-4C58-98D0-7E256328F5C6Q27007111-A4789957-6BB9-4AC5-BB09-B161FAB22E82Q28083676-3E5597C3-2C87-4315-A473-05E59EC303F2Q28564310-52361897-361B-42B8-8AFF-40B4C3FE3BA2Q28577516-E6C8AE59-9175-4F39-AD71-C93D68EF7168Q28584295-8B1D14F4-33EA-4732-8820-05979F372CFEQ28730878-3E0D1747-764A-468D-98C3-A57CFD9D3C96Q29248994-F1CF6FA5-BFCA-4087-ADA0-926B643A785EQ31083347-1D14BAFA-C67E-415B-92C7-84AD2654203EQ33625727-58CC978D-851D-4F81-9552-E9D0DE3C6CC9Q33645320-FA220CBE-EB4F-447A-89EA-F22EC4C4D8C5Q33701506-23F0DC5B-5C4F-49D1-8C41-8E019913AD5EQ33713517-CAC11EC1-A399-45A0-99B1-70CB2F16BF1EQ33769452-4F6B8431-E592-44BF-9DBF-D152B30AF03AQ33786878-5104FA88-F27A-4CAC-9A84-6A61AD44987BQ33791268-3DA0B64E-362C-4D6D-AD9C-095EAFB458CBQ33914624-5E91788B-3D03-4342-B31C-FB494A72F7C3Q34014053-3A410CE7-2452-45B9-BE03-55E64CEE2A61Q34047929-CBA468FD-67EA-4674-9555-5148FE9831DEQ34077613-A4F5939C-7183-41A7-A43A-2D4919A21A3AQ34082890-12BA1AAF-8671-4CB5-B7E2-FF9EEBEAD6AEQ34237700-E4C867A0-C2DA-481A-8263-B79DF61D0165Q34335696-74EE51F1-FC8E-4A68-875F-8A3A3CBE2C79Q34355343-4A6B411A-6557-44FD-B160-DF3969EBEB7CQ34364177-2F33DFB8-0456-485F-9EF0-A838AE1545B6Q34433667-06AEB13D-0441-4AD9-979C-4950063E8444Q34575640-98F0519F-8F80-48D0-B7A2-94AE2710BEA8Q34600290-F6BF1707-5BB2-4EF1-81AF-C27F5B7E32DBQ34603026-503C3FDB-06BA-4A27-B947-4C8A47ED3C5AQ34615514-0DBB9C1F-0CDC-4485-B785-99971612A290Q34790591-3C26F399-F9C7-4332-A6C4-0CECDFFFAA20Q34919840-7A944950-6803-4F3B-A949-A54CB65AF470Q34972210-E8B1ED62-1884-497E-80B6-7E628EF49E2BQ35005977-0F71FF8A-17FE-4D57-A4F0-13F39C01C1D4Q35071239-4FE5255F-319E-4577-87F8-71858A99C708Q36104687-B8666903-5DB3-43CE-9DF3-BD14322726BC
P2860
Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inducible nitric oxide synthas ...... kdown in diabetic retinopathy.
@ast
Inducible nitric oxide synthas ...... kdown in diabetic retinopathy.
@en
Inducible nitric oxide synthas ...... kdown in diabetic retinopathy.
@nl
type
label
Inducible nitric oxide synthas ...... kdown in diabetic retinopathy.
@ast
Inducible nitric oxide synthas ...... kdown in diabetic retinopathy.
@en
Inducible nitric oxide synthas ...... kdown in diabetic retinopathy.
@nl
prefLabel
Inducible nitric oxide synthas ...... kdown in diabetic retinopathy.
@ast
Inducible nitric oxide synthas ...... kdown in diabetic retinopathy.
@en
Inducible nitric oxide synthas ...... kdown in diabetic retinopathy.
@nl
P2093
P50
P356
P1476
Inducible nitric oxide synthas ...... kdown in diabetic retinopathy.
@en
P2093
António Francisco Ambrósio
Ayyakkannu Manivannan
John V Forrester
José Cunha-Vaz
Ken-Ichi Hosoya
P304
P356
10.1167/IOVS.07-0112
P407
P577
2007-11-01T00:00:00Z